Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients

Key facts

Sponsor

AHS Cancer Control Alberta

Principal Investigator

Mark Haykowsky, PhD

University of Alberta

Enrollment

30 enrolled

Eligibility

18 years · MALE

Timeline

2008 – 2012

Study locations (1)

• Cross Cancer Institute, Edmonton, Alberta, Canada

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Germ cell tumor of testis

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07498959
  Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer
  Sahlgrenska University Hospital
• RECRUITINGPHASE1NCT07218913
  Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
  City of Hope Medical Center
• RECRUITINGPHASE2NCT06866964
  A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
  Wake Forest University Health Sciences
• RECRUITINGPHASE2NCT06932458
  A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases
  Western University, Canada
• RECRUITINGNANCT05588700
  Impact of a Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor Patients
  Centre Leon Berard
• RECRUITINGNCT06309745
  THERApy De-escalation for TESTicular Cancer
  Queen Mary University of London
• RECRUITINGPHASE1NCT06276491
  Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
  Xencor, Inc.
• RECRUITINGNANCT06133543
  Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer
  Heinrich-Heine University, Duesseldorf

See all trials for Germ cell tumor of testis →